Profit Taking in Amarin (AMRN) as Trading Resumes, Shares Around $15
Tweet Send to a FriendGet Alerts AMRN Hot Sheet
Down)
Trade AMRN Now!
After an initial move slightly higher, traders in shares of Amarin (Nasdaq: AMRN) are now taking profits following news of Thursday evening's FDA approval of Vascepa.
The stock swung higher upon resumption, but is now down about 2 percent to around $15. Shares closed at $15.31 on Thursday.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The stock swung higher upon resumption, but is now down about 2 percent to around $15. Shares closed at $15.31 on Thursday.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Amarin's (AMRN) Vascepa Not in FDA Orange Book for April
- UPDATE: Kansas City Southern (KSU) to Replace Dean Foods (DF) in S&P 500; WhiteWave Foods (WWAV) to S&P MidCap 400
- Tesla (TSLA) on Watch Ahead of Equity Offering Pricing
Create E-mail Alert Related Categories
Momentum Movers, Trader Talk
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
